0001209191-16-110139.txt : 20160323 0001209191-16-110139.hdr.sgml : 20160323 20160323085344 ACCESSION NUMBER: 0001209191-16-110139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160321 FILED AS OF DATE: 20160323 DATE AS OF CHANGE: 20160323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pedder Simon CENTRAL INDEX KEY: 0001316736 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 161522579 MAIL ADDRESS: STREET 1: C/O CHELSEA THERAPEUTICS, INC. STREET 2: 13950 BALLANTYNE CORPORATE PL SUITE 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-03-21 0 0000908259 OXIGENE INC OXGN 0001316736 Pedder Simon C/O OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 0.7277 2016-03-21 4 A 0 99711 0.00 A 2022-03-21 Common Stock 99711 99711 D Dr. Pedder was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), in connection with his appointment to the Board of Directors pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy. The Stock Options will vest in full on March 21, 2019, subject to Dr. Pedder's continued service on the Board of Directors as of such date. Megan N. Gates, attorney-in-fact 2016-03-23 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT

Exhibit 24.1

POWER OF ATTORNEY

	Know all by these presents, that the undersigned hereby constitutes and
appoints each of William D. Schwieterman, the Chief Executive Officer of
OXiGENE, Inc. (the "Company"), and Matthew Loar, the Chief Financial Officer of
the Company, and Megan N. Gates, Andrea J. Paul, Melanie D. Ruthrauff, Kaoru
Suzuki and Joan Raulston of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.,
signing singly, with full power of substitution, the undersigned's true and
lawful attorney-in-fact to:

	(1)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or 10% shareholder of the Company, forms and authentication
documents for EDGAR Filing Access;

	(2)	do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such forms and
authentication documents;

	(3)	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or 10% shareholder of the Company, Forms 3, 4 and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended, and the rules thereunder;

	(4)	do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute any such Form 3, 4 or 5
and timely file such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and

	(5)	take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interests of, or legally required by the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed this 21st day of March, 2016.




/s/ Simon Pedder
Signature

Name:  Simon Pedder